Mandana Mohyeddin Bonab

Summary

Affiliation: Tehran University of Medical Sciences
Country: Iran

Publications

  1. ncbi request reprint Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?
    M Mohyeddin Bonab
    Heamatology, Oncology, and BMT Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
    Transplant Proc 36:3190-3. 2004
  2. pdf Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study
    Mandana Mohyeddin Bonab
    Hematology Oncology and BMT Research Center, Tehran, Iran
    Iran J Immunol 4:50-7. 2007
  3. doi request reprint Evaluation of cytokines in multiple sclerosis patients treated with mesenchymal stem cells
    Mandana Mohyeddin Bonab
    Research Center of Molecular Immunology, Tehran University of Medical Sciences, Tehran, Iran
    Arch Med Res 44:266-72. 2013
  4. pmc Aging of mesenchymal stem cell in vitro
    Mandana Mohyeddin Bonab
    Hematology Oncology and BMT Research Center, Shariati Hospital, Tehran University of Medical Sciences, Iran
    BMC Cell Biol 7:14. 2006
  5. ncbi request reprint Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction
    Mandana Mohyeddin-Bonab
    Immunogenetics Laboratory, Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 10:467-73. 2007
  6. ncbi request reprint Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study
    Mandana Mohyeddin Bonab
    Immunogenetics Research Centre, Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran
    Curr Stem Cell Res Ther 7:407-14. 2012
  7. ncbi request reprint Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis
    Mehdi Mohamadnejad
    Digestive Disease Research Center, Medical Sciences Tehran University, Tehran, Iran
    Arch Iran Med 10:459-66. 2007
  8. ncbi request reprint Microchimerism and stem cell transplantation in multiple sclerosis
    Behrouz Nikbin
    Immunogenetic Research Center, Department of Immunology, College of Medicine, Tehran University of Medical Sciences, Tehran 14155, Iran
    Int Rev Neurobiol 79:173-202. 2007
  9. ncbi request reprint Role of B cells in pathogenesis of multiple sclerosis
    Behrouz Nikbin
    Department of Immunology, Immunogenetic Research Center, College of Medicine, Tehran University of Medical Sciences, Tehran 14155, Iran
    Int Rev Neurobiol 79:13-42. 2007

Collaborators

  • Kamran Alimoghaddam
  • Hossein Baharvand
  • Reza Malekzadeh
  • Mehdi Mohamadnejad
  • Farzaneh Agha-Hosseini
  • Behrouz Nikbin
  • Mandana Mohyeddin Bonab
  • Fatemeh Talebian
  • Mandana Mohyeddin-Bonab
  • Ardeshir Ghavamzadeh
  • M Mohyeddin Bonab
  • Aida Aghsaie
  • Mahboubeh Yazdanifar
  • Maryam Mohajeri
  • Mohammad Ali Sahraian
  • Behrooz Nikbin
  • Ali Farazmand
  • Massoud Eslami
  • Mehdi Sanatkar
  • Hamid Mirkhani
  • Masuod Gasemi
  • Kamran Alimoghaddom
  • Hassan Radmehr
  • Mohamad Reza Mohamad-Hassani
  • Hassan Emami-Razavi
  • Farnaz Hooshmand
  • Amir Farhig-Parsa
  • Mahmood Ghasemi al-Mohamad
  • Mahmood Gholam Alemohammad
  • Ali Akbar Solimani
  • Jamshid Lotfi
  • Farideh Khosravi
  • Sepideh Yazdanbakhsh
  • Mehrdad Salehi
  • A Ghavamzadeh
  • F Forouzia
  • S Vatandoust
  • M Jahani

Detail Information

Publications9

  1. ncbi request reprint Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?
    M Mohyeddin Bonab
    Heamatology, Oncology, and BMT Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
    Transplant Proc 36:3190-3. 2004
    ..These data may provide useful guidelines to choose strategies for treatment and prevention...
  2. pdf Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study
    Mandana Mohyeddin Bonab
    Hematology Oncology and BMT Research Center, Tehran, Iran
    Iran J Immunol 4:50-7. 2007
    ..Mesenchymal stem cells (MSCs) with their potential to differentiate into mesodermal and non-mesodermal lineages have several immunomodulatory characteristics. These properties make them promising tools in cell and gene therapy...
  3. doi request reprint Evaluation of cytokines in multiple sclerosis patients treated with mesenchymal stem cells
    Mandana Mohyeddin Bonab
    Research Center of Molecular Immunology, Tehran University of Medical Sciences, Tehran, Iran
    Arch Med Res 44:266-72. 2013
    ..Cytokines have a profound effect on the resultant immune responses. This study aims to evaluate variations in the cytokine profile of multiple sclerosis patients treated with autologous MSC...
  4. pmc Aging of mesenchymal stem cell in vitro
    Mandana Mohyeddin Bonab
    Hematology Oncology and BMT Research Center, Shariati Hospital, Tehran University of Medical Sciences, Iran
    BMC Cell Biol 7:14. 2006
    ..The low frequency of this subpopulation of stem cells in bone marrow (BM) necessitates their in vitro expansion prior to clinical use. We evaluated the effect of long term culture on the senescence of these cells...
  5. ncbi request reprint Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction
    Mandana Mohyeddin-Bonab
    Immunogenetics Laboratory, Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 10:467-73. 2007
    ..In this study, we investigated the efficacy of autologous bone marrow derived mesenchymal stem cells in improving heart function in patients with old myocardial infarction...
  6. ncbi request reprint Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study
    Mandana Mohyeddin Bonab
    Immunogenetics Research Centre, Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran
    Curr Stem Cell Res Ther 7:407-14. 2012
    ..Repeating the study with a larger sample size, booster injections and longer follow-up using a controlled study design is advised...
  7. ncbi request reprint Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis
    Mehdi Mohamadnejad
    Digestive Disease Research Center, Medical Sciences Tehran University, Tehran, Iran
    Arch Iran Med 10:459-66. 2007
    ..The objective of this study was to determine the safety and feasibility of autologous bone marrow-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis...
  8. ncbi request reprint Microchimerism and stem cell transplantation in multiple sclerosis
    Behrouz Nikbin
    Immunogenetic Research Center, Department of Immunology, College of Medicine, Tehran University of Medical Sciences, Tehran 14155, Iran
    Int Rev Neurobiol 79:173-202. 2007
    ..Due to the dichotomous properties of MSC, suppressing aggressive immune dysfunction while promoting damaged tissue repair, they may be appropriate therapy for MS...
  9. ncbi request reprint Role of B cells in pathogenesis of multiple sclerosis
    Behrouz Nikbin
    Department of Immunology, Immunogenetic Research Center, College of Medicine, Tehran University of Medical Sciences, Tehran 14155, Iran
    Int Rev Neurobiol 79:13-42. 2007
    ..For this reason, further investigation is necessary to determine whether depletion of B cells or antibodies may restore immune function...